Mizuho Maintains Outperform on Axsome Therapeutics, Lowers Price Target to $306

Benzinga · 2d ago
Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ:AXSM) with a Outperform and lowers the price target from $310 to $306.